Advertisement
UK markets close in 4 hours 28 minutes
  • FTSE 100

    7,831.97
    -45.08 (-0.57%)
     
  • FTSE 250

    19,283.22
    -167.45 (-0.86%)
     
  • AIM

    741.28
    -4.01 (-0.54%)
     
  • GBP/EUR

    1.1675
    -0.0008 (-0.07%)
     
  • GBP/USD

    1.2433
    -0.0005 (-0.04%)
     
  • Bitcoin GBP

    52,105.02
    +2,354.96 (+4.73%)
     
  • CMC Crypto 200

    1,329.48
    +16.85 (+1.30%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.27
    -0.46 (-0.56%)
     
  • GOLD FUTURES

    2,396.60
    -1.40 (-0.06%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,721.76
    -115.64 (-0.65%)
     
  • CAC 40

    7,998.33
    -24.93 (-0.31%)
     

Sarepta stock soars as early-stage gene therapy data shows promise

(Reuters) - Sarepta Therapeutics Inc reported promising results on Tuesday from an early-stage study testing its gene therapy in patients with Duchenne muscular dystrophy (DMD), driving the company's shares up 60 percent.